Tipologia bando:
Assegni di ricerca
Codice bando:
AR-B 3/2021
SSD:
A randomized, double blind placebo controlled clinical trial to assess the efficacy and safety of sitagliptin on bone measures in women affected by type 2 diabetes. A gender-oriented approach to address a gender-specific frailty. The SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) study
Bando:
Data pubblicazione:
Gio, 04/03/2021
Data scadenza:
Sab, 03/04/2021
decreto approvazione atti:
Allegati vari:
Criteri di valutazione:
SPC:
2021-0070-1352-174415